力诺药包
(301188)
| 流通市值：178.88亿 | | | 总市值：178.88亿 |
| 流通股本：2.68亿 | | | 总股本：2.68亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 320,071,196.64 | 981,471,630.66 | 721,014,626.29 | 498,727,431.13 |
| 营业收入 | 320,071,196.64 | 981,471,630.66 | 721,014,626.29 | 498,727,431.13 |
| 二、营业总成本 | 271,686,611.05 | 954,115,373.27 | 684,502,021.07 | 467,081,428.49 |
| 营业成本 | 234,074,349.2 | 774,136,157.48 | 568,340,738.68 | 391,534,631.89 |
| 税金及附加 | 1,767,141.92 | 6,972,239.88 | 5,006,057.35 | 3,325,889.53 |
| 销售费用 | 10,819,878.81 | 61,709,079.18 | 42,451,440.47 | 26,709,506.65 |
| 管理费用 | 11,676,070.26 | 52,447,937.1 | 28,022,618.53 | 18,749,429.77 |
| 研发费用 | 7,291,347.15 | 34,365,649.87 | 23,442,506.08 | 16,030,809.79 |
| 财务费用 | 6,057,823.71 | 24,484,309.76 | 17,238,659.96 | 10,731,160.86 |
| 其中:利息费用 | 4,439,549.21 | 26,741,713.99 | 19,196,541.06 | 13,151,383.79 |
| 其中:利息收入 | 503,040.26 | 3,493,312.95 | 2,794,658.46 | 1,870,930.46 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 252,048.79 | 1,666,557.35 | 1,410,220.4 | 1,105,578.17 |
| 加:投资收益 | 3,077,465.48 | 10,861,449.23 | 6,550,698.72 | 4,259,251.16 |
| 资产处置收益 | - | 2,402,286.5 | 2,380,717.62 | 2,380,717.62 |
| 资产减值损失(新) | -2,896,023.59 | -8,453,402.05 | -3,222,299.47 | -3,477,095.8 |
| 信用减值损失(新) | -1,054,690.03 | -1,846,877.52 | -1,188,106.92 | -1,055,724.74 |
| 其他收益 | 2,576,132.4 | 18,635,967.6 | 15,475,206.17 | 11,472,154.24 |
| 四、营业利润 | 50,339,518.64 | 50,622,238.5 | 57,919,041.74 | 46,330,883.29 |
| 加:营业外收入 | 331,441.94 | 3,616.3 | 613.79 | 9.18 |
| 减:营业外支出 | 25,106.58 | 1,406,112.94 | 36,038.47 | 6,037.5 |
| 五、利润总额 | 50,645,854 | 49,219,741.86 | 57,883,617.06 | 46,324,854.97 |
| 减:所得税费用 | 9,643,378.99 | 9,559,312.48 | 7,001,282.53 | 5,357,389.41 |
| 六、净利润 | 41,002,475.01 | 39,660,429.38 | 50,882,334.53 | 40,967,465.56 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 41,002,475.01 | 39,660,429.38 | 50,882,334.53 | 40,967,465.56 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 41,002,475.01 | 39,660,429.38 | 50,882,334.53 | 40,967,465.56 |
| 扣除非经常损益后的净利润 | 39,877,648.32 | 29,385,871.52 | 35,575,952.14 | 28,940,875.24 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.17 | 0.17 | 0.22 | 0.18 |
| (二)稀释每股收益 | 0.17 | 0.17 | 0.22 | 0.18 |
| 八、其他综合收益 | - | 153.81 | - | - |
| 归属于母公司股东的其他综合收益 | - | 153.81 | - | - |
| 九、综合收益总额 | 41,002,475.01 | 39,660,583.19 | 50,882,334.53 | 40,967,465.56 |
| 归属于母公司股东的综合收益总额 | 41,002,475.01 | 39,660,583.19 | 50,882,334.53 | 40,967,465.56 |
| 公告日期 | 2026-04-23 | 2026-04-23 | 2025-10-28 | 2025-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |